MINNEAPOLIS, MN, August 22, 2016 – IMRIS, Deerfield Imaging, the global leader in intraoperative imaging, has recently celebrated its 1-year anniversary under the ownership of Deerfield Management.
Over the past year IMRIS, Deerfield Imaging brought in new leadership with the addition of Dr. Gregory Sorensen, as Executive Chairman and Andrew Flanagan, as President and CEO.
With new leadership, IMRIS Deerfield Imaging has refocused its priorities dedicated to customer success, value realization and a renewed emphasis on neurosurgery. Under this strategy, IMRIS, Deerfield Imaging has launched the Office of the Customer, a dedicated team to focus on customer success and has adopted and cascaded a new a value realization methodology to use with current and prospective customers that enables the customer to better understand the strong return on investment our IMRIS Surgical Theatre enables.
Since August 2015, the company has experienced three profitable quarters and overall profitability above projections.
“Over the past year, we have enhanced our quality-focused team and have streamlined our processes to make us more efficient,” said Andy Flanagan, IMRIS’ President and CEO, “and have realized greater profitability as a result.”
About IMRIS, Deerfield Imaging
As a leader in image guided therapy solutions, IMRIS, Deerfield Imaging provides optimized fully integrated image-guided therapy environments that serve to address the important needs of patients, clinicians and hospitals by delivering timely information on surgical targets and results to clinicians for use during surgical or interventional procedures. The IMRIS Surgical Theatre incorporates MRI, CT and angiography into multi-purpose surgical suites which provide advanced intraoperative imaging directly within operating rooms. IMRIS products are sold globally to hospitals in the neurosurgical, spinal, cardiovascular, and orthopedic markets.
For more information, please visit www.imris.com.